Shanghai Junshi Biosciences Co Ltd (688180) — Capital Reinvestment Ratio
Latest as of March 2022:
0.17x
Shanghai Junshi Biosciences Co Ltd (688180) has a Capital Reinvestment Ratio of 0.17x as of March 2022, meaning it reinvests 0% of its operating cash flow (CN¥570.43 Million) in capital expenditures (CN¥97.07 Million). See Shanghai Junshi Biosciences Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥570.43 Million
CNY
Capital Expenditures
CN¥97.07 Million
CNY
Data as of
Mar 2022
Most recent filing
Annual Capital Reinvestment Ratio for Shanghai Junshi Biosciences Co Ltd (None–None)
Year-by-year Capital Reinvestment Ratio for Shanghai Junshi Biosciences Co Ltd from None to None. For live market cap and broader valuation context, see market value of Shanghai Junshi Biosciences Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow